EUVIMEDEUVIMED entdecken
Crossref

In vitro biophysical and pharmacological profiling predicts in vivo efficacy of anti-carfentanil monoclonal antibodies in mice

Brooke K Hoppe, Robert W Seaman, Bryan Hannon, Elaine Gay, Dustin Hicks, Carly Baehr, Haydon J Hill, Sujata G Pandit, Austin Baldridge, Vanessa Berner, David P AuCoin, Scott Runyon und 1 weitere

Biochemical and Biophysical Research Communications · 2025

DOI: 10.1016/j.bbrc.2025.151995 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2025. Verfasst von Brooke K Hoppe und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle, WA, 98104, USA. Hauptthemen laut MEDLINE: Fentanyl, Antibodies, Monoclonal, Respiratory Insufficiency, Analgesics, Opioid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: NIDA NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synthetic opioids, including fentanyl and its potent analogs (F/FA) such as carfentanil, are involved in the majority of fatal and non-fatal overdoses in the United States. Despite the availability of the opioid receptor antagonists naloxone and nalmefene to treat overdose, this public health crisis highlights the need for a broader range of treatment options. To support the clinical value of drug-specific monoclonal antibodies (mAbs) as therapeutics for reducing opioid overdose toxicity, the current studies performed in vitro characterization of anti-carfentanil mAbs, and in vivo assessment of their efficacy against carfentanil-induced respiratory depression in mice. To probe the binding interaction between mAbs and carfentanil, this study employed a human mu-opioid receptor (hMOR) calcium mobilization assay and differential scanning fluorimetry. Two of the five mAbs significantly reversed carfentanil-induced respiratory depression in mice. The degree of thermal stabilization of carfentanil-bound mAb correlated with greater efficacy of a given mAb to reverse carfentanil-induced respiratory depression in mice. The reduction of carfentanil-induced hMOR activation stratified mAbs into categories that corresponded, albeit not significantly, to greater in vivo efficacy. These studies indicate that biophysical and pharmacological in vitro analyses can predict the in vivo efficacy of novel mAbs, and support further investigation of mAb-based therapeutics against carfentanil toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FentanylAntibodies, MonoclonalRespiratory InsufficiencyAnalgesics, OpioidAnimalsMiceReceptors, Opioid, muHumansMale

Stichwörter der Autor:innen

CarfentanilDifferential scanning fluorimetryIn vitro screeningMonoclonal antibodiesReversal of respiratory depression

Substanzen

FentanylAntibodies, MonoclonalcarfentanilReceptors, Opioid, muAnalgesics, Opioid

Autor:innen und Institutionen

  • Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle, WA, 98104, USA.
  • Center for Drug Discovery, Research Triangle Institute International, Research Triangle Park, NC, 27709, USA.
  • Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN, 55455, USA.
  • Department of Microbiology and Immunology, University of Nevada Reno, Reno, NV, 89557, USA.
  • Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle, WA, 98104, USA; Department of Pharmacology, School of Medicine, University of Washington, Seattle, WA, 98104, USA;…

Förderung

  • NIDA NIH HHS
  • National Institutes of Health

Zitieren

APA

Hoppe, B. K., Seaman, R. W., Hannon, B., Gay, E., Hicks, D., Baehr, C., Hill, H. J., Pandit, S. G., Baldridge, A., Berner, V., AuCoin, D. P., Runyon, S., & Pravetoni, M. (2025). In vitro biophysical and pharmacological profiling predicts in vivo efficacy of anti-carfentanil monoclonal antibodies in mice. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2025.151995

Vancouver

Hoppe BK, Seaman RW, Hannon B, Gay E, Hicks D, Baehr C, et al. In vitro biophysical and pharmacological profiling predicts in vivo efficacy of anti-carfentanil monoclonal antibodies in mice. Biochemical and Biophysical Research Communications. 2025. doi:10.1016/j.bbrc.2025.151995

BibTeX
@article{Hoppe2025,
  author = {Hoppe, Brooke K and Seaman, Robert W and Hannon, Bryan and Gay, Elaine and Hicks, Dustin and Baehr, Carly and Hill, Haydon J and Pandit, Sujata G and Baldridge, Austin and Berner, Vanessa and AuCoin, David P and Runyon, Scott and Pravetoni, Marco},
  title = {In vitro biophysical and pharmacological profiling predicts in vivo efficacy of anti-carfentanil monoclonal antibodies in mice},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2025},
  doi = {10.1016/j.bbrc.2025.151995}
}
Kostenlos starten →